600557 Stock Overview
Researches and develops, produces, and sells Chinese medicines. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Jiangsu Kanion Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.03 |
| 52 Week High | CN¥24.09 |
| 52 Week Low | CN¥11.77 |
| Beta | 0.46 |
| 1 Month Change | -1.82% |
| 3 Month Change | 10.56% |
| 1 Year Change | -31.26% |
| 3 Year Change | 17.11% |
| 5 Year Change | -2.37% |
| Change since IPO | 408.16% |
Recent News & Updates
Recent updates
Jiangsu Kanion Pharmaceutical Co.,Ltd.'s (SHSE:600557) Shares Lagging The Market But So Is The Business
Dec 03
With EPS Growth And More, Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Makes An Interesting Case
Aug 19Here's Why Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Has Caught The Eye Of Investors
May 21Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality
Apr 25Jiangsu Kanion Pharmaceutical Co.,Ltd.'s (SHSE:600557) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Mar 04Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE:600557) Shares Fly 34% But Investors Aren't Buying For Growth
Mar 04Shareholder Returns
| 600557 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.9% | -1.9% | -1.2% |
| 1Y | -31.3% | -1.8% | 11.8% |
Return vs Industry: 600557 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 600557 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 600557 volatility | |
|---|---|
| 600557 Average Weekly Movement | 6.5% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600557 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600557's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | 5,443 | Yongchun Yang | www.kanion.com |
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others.
Jiangsu Kanion Pharmaceutical Co.,Ltd. Fundamentals Summary
| 600557 fundamental statistics | |
|---|---|
| Market cap | CN¥8.16b |
| Earnings (TTM) | CN¥544.35m |
| Revenue (TTM) | CN¥4.48b |
14.7x
P/E Ratio1.8x
P/S RatioIs 600557 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600557 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.48b |
| Cost of Revenue | CN¥1.14b |
| Gross Profit | CN¥3.34b |
| Other Expenses | CN¥2.80b |
| Earnings | CN¥544.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.96 |
| Gross Margin | 74.61% |
| Net Profit Margin | 12.15% |
| Debt/Equity Ratio | 0.04% |
How did 600557 perform over the long term?
See historical performance and comparisonDividends
2.7%
Current Dividend Yield40%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 08:53 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Kanion Pharmaceutical Co.,Ltd. is covered by 31 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xin Zhang | AJ Securities Co., Ltd |
| Zhi Xue Diao | Avic Securities Co., Ltd |
| Changming He | BOCI Research Ltd. |